| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
| 01/06/1998 | US5705151 Anticarcinogenic agents using liposomes and genetic engineering |
| 01/02/1998 | DE19627352A1 Vakzine gegen Kohlenhydrat-Antigene Vaccine against carbohydrate antigens |
| 12/31/1997 | WO1997049825A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049817A1 Brain glycogen phosphorylase cancer antigen |
| 12/31/1997 | WO1997049812A2 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | WO1997049809A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 12/31/1997 | WO1997049805A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 12/31/1997 | WO1997049428A1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 12/31/1997 | WO1997049426A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient |
| 12/31/1997 | WO1997049425A1 Vaccine comprising antigens bound to carriers through labile bonds |
| 12/31/1997 | WO1997049423A2 Liposomal influenza vaccine composition and method |
| 12/31/1997 | WO1997049421A1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors |
| 12/31/1997 | WO1997049416A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | WO1997045009A3 Long-term shelf preservation by vitrification |
| 12/31/1997 | WO1997030159A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 12/31/1997 | CN1036838C Method for prepn. of vaccine |
| 12/31/1997 | CA2259636A1 Process for extracting and purifying recombinant, non-lipidised osp-protein |
| 12/31/1997 | CA2258608A1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors |
| 12/31/1997 | CA2258564A1 Brain glycogen phosphorylase cancer antigen |
| 12/31/1997 | CA2258168A1 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/31/1997 | CA2254782A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient |
| 12/30/1997 | US5703221 Stealth virus nucleic acids and related methods |
| 12/30/1997 | US5703219 Hybrids |
| 12/30/1997 | US5703213 Monoclonal antibodies which recognize an adenocarcinoma cell antigen |
| 12/30/1997 | US5703207 Protein active in humoral hypercalcemia of malignancy-PTHrP |
| 12/30/1997 | US5703057 Expression library immunization |
| 12/30/1997 | US5703051 Therapeutic uses of melanin |
| 12/30/1997 | US5703048 Hepatocyte growth factor |
| 12/30/1997 | US5702946 Interleukins |
| 12/30/1997 | US5702934 Processes for producing an enzyme |
| 12/30/1997 | US5702918 HIV-2 envelope polypeptides |
| 12/30/1997 | US5702917 Polynucleotides encoding human ICAM-4 |
| 12/30/1997 | US5702916 Biological Containment |
| 12/30/1997 | US5702907 Nucleotide sequence |
| 12/30/1997 | US5702890 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 12/30/1997 | US5702708 Salmonicida iron regulated protein and lipopolysaccharide vaccine |
| 12/30/1997 | US5702707 A polypeptide including amino acid sequence extending from position 92 to 109 of p17 gag protein of hiv-1, total number of amino acid does not exceed about 40; basis for vaccine |
| 12/30/1997 | US5702705 Antibody methods for the treatment of a hormone-mediated disease |
| 12/30/1997 | US5702704 Antibodies to in vivo advanced glycosylation endproducts |
| 12/30/1997 | CA1339606C Polypeptides complementary to peptides or proteins having an amino acid sequence or necleotide coding sequence at least partially known |
| 12/29/1997 | EP0814159A2 Transgenic non-human animals capable of producing heterologous antibodies |
| 12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |
| 12/29/1997 | EP0814090A1 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection |
| 12/29/1997 | EP0814089A2 Respiratory syncytial virus: vaccines and diagnostic assays |
| 12/29/1997 | EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 12/29/1997 | EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 12/29/1997 | EP0813423A1 Composition to ameliorate osteolysis and metastasis |
| 12/29/1997 | EP0813422A1 Compositions and methods for stimulating antibody class switching |
| 12/29/1997 | EP0813419A1 Modulators of regulatory proteins |
| 12/29/1997 | EP0752104B1 Differential expansion of fetal stem cells in the maternal circulation for use in prenatal genetic analysis |
| 12/29/1997 | EP0666904B1 Attenuated strains of aeromonas salmonicida useful as fish vaccines |
| 12/29/1997 | EP0655928B1 Use of an homeopathic product for the manufacture of a medicament for treatment of metabolic diseases |
| 12/29/1997 | EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 12/29/1997 | EP0552296B1 Mouse monoclonal antibodies |
| 12/24/1997 | WO1997048805A1 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF |
| 12/24/1997 | WO1997048802A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 12/24/1997 | WO1997048728A1 Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity |
| 12/24/1997 | WO1997048727A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 12/24/1997 | WO1997048418A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 12/24/1997 | WO1997048417A1 Vaccine to prevent streptococcal endocarditis |
| 12/24/1997 | WO1997048370A2 Vaccines comprising synthetic genes |
| 12/24/1997 | WO1997043314A3 Collagen binding protein compositions and methods of use |
| 12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
| 12/24/1997 | WO1997033909A3 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 12/24/1997 | CN1168699A Protein kinase NPK-llo |
| 12/24/1997 | CN1168698A Recombinant proteins of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 12/24/1997 | CN1168695A Inhibitor of stem cell proliferation and uses thereof |
| 12/24/1997 | CN1168693A Method for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 12/24/1997 | CN1168679A Monoclonal antibody fragments having immunosuppressant activity |
| 12/24/1997 | CN1168677A Novel peptides derived from autoantigent for use in immunotherapy of autoimmune diseases |
| 12/24/1997 | CN1168674A Synthetic peptides and vaccines comprising same |
| 12/24/1997 | CN1168629A Adjuvant for a vaccine composition |
| 12/24/1997 | CA2294433A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 12/24/1997 | CA2258568A1 Vaccines comprising synthetic genes |
| 12/24/1997 | CA2258515A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 12/24/1997 | CA2258011A1 Vaccine to prevent streptococcal endocarditis |
| 12/24/1997 | CA2257855A1 Human thymosin .beta.15 gene, protein and uses thereof |
| 12/24/1997 | CA2257130A1 Human camp-dependent protein kinase inhibitor homolog |
| 12/23/1997 | US5700928 Polynucleotide encoding saliva binding protein |
| 12/23/1997 | US5700907 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 12/23/1997 | US5700906 Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein |
| 12/23/1997 | US5700787 Capsular polysaccharide immunomodulator |
| 12/23/1997 | US5700778 Inhibit synaptic transmission |
| 12/23/1997 | US5700694 Method to detect bone and other connective tissue disorders in humans and animals |
| 12/23/1997 | US5700693 Method to detect bone and other connective tissue disorders in humans and animals |
| 12/23/1997 | US5700680 Fusion proteins |
| 12/23/1997 | US5700658 Purified, isolated polynucleotide coding for intercellular adhesion molecule protein |
| 12/23/1997 | US5700649 Method of detection of urinary tumor associated antigen |
| 12/23/1997 | US5700635 HIV-1 gag cytotoxic T-lymphocyte epitope and method of use |
| 12/23/1997 | US5700469 HIV-1 core protein fragments |
| 12/23/1997 | US5700466 Culture product from hybridoma cell |
| 12/23/1997 | US5700459 Polybase and polyacid, one of which is a polymer, active material comprising antiinflammatory agent, antibiotic, enzyme inhibitor |
| 12/18/1997 | WO1997047740A2 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A β-TUBULIN |
| 12/18/1997 | WO1997047732A2 Hexameric fusion proteins and uses therefor |
| 12/18/1997 | WO1997047654A1 Human monoclonal antibodies to the hepatitis b surface antigen |
| 12/18/1997 | WO1997047649A1 Paralysis tick neurotoxin |
| 12/18/1997 | WO1997047648A1 T cell epitope peptide |
| 12/18/1997 | WO1997047646A1 Helicobacter pylori adhesin binding group antigen |